Zhaozhong Zhu

Massachusetts General Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (7)

Year:

2026

Supplementary Table 7 shows the Mendelian randomization estimates for the potential causal effect of genetic liability to allergic diseases and asthma on colorectal cancer risk; leave one genetic variant out sensitivity analyses.

Year:

2025

Supplementary Table 4 shows the genome-wide significant variants related to (a) allergic diseases (asthma, hay fever, or eczema), (b) early-onset asthma, (c) later-onset asthma, (d) atopic asthma, and (e) hay fever or eczema and their association with other traits in previous genome-wide association studies.

Year:

2025

Supplementary Table 2 shows the genetic variant overlap (same variants or variants in LD R2>0.001 between exposures) for the three exposures tested in our Mendelian randomization analyses (i.e., genetic liability to allergic diseases and their overlap with variants associated with asthma-related phenotypes and hay fever/allergic rhinitis or eczema).

Year:

2025

Background: The tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used Mendelian randomization (MR) to examine potential causal associations of allergies with the risk of overall and early-onset colorectal cancer. Methods: Genome-wide association study summary statistical data were used to identify genetic variants associated with allergic diseases ( N variants = 65) and individual allergic conditions (asthma, hay fever/allergic rhinitis, and eczema). Using two-sample MR, we examined these variants in relation to incident overall ( N cases = 52,775 cases) and early-onset colorectal cancer ( N cases = 6,176). The mediating role of white blood cells was examined using multivariable MR. Results: In inverse-variance–weighted models, genetic liability to allergic diseases was inversely associated with overall {OR per log (odds) = 0.90 [95% confidence interval (CI), 0.85–0.96]; P P = 0.01]. Similar inverse associations were found for hay fever/allergic rhinitis or eczema, whereas no evidence of association was found between liability to asthma-related phenotypes and colorectal cancer risk. Multivariable MR adjustment for eosinophils weakened the inverse associations for liability to allergic diseases for overall [OR = 0.96 (95% CI, 0.89–1.03); P = 0.26] and early-onset colorectal cancer [OR = 0.86 (95% CI, 0.73–1.01); P = 0.06]. Conclusions: Our study supports a potential causal association between liability to allergic diseases, specifically hay fever/allergic rhinitis or eczema, and colorectal cancer, possibly at least in part mediated via eosinophil counts. Impact: Our results provide evidence that allergic responses may also have a role in immunosurveillance against colorectal cancer.

Year:

2025

Supplementary Table 3 shows the number of cancer cases and controls in the Mendelian randomization study of genetic liability to allergic diseases and asthma-related phenotypes and risk of colorectal cancer.

Year:

2025

Background Infants with bronchiolitis are at increased risk of developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition. However, little is known about its biologically distinct subgroups based on the integrated metagenome and asthma genetic risk signature and their longitudinal relationships with asthma development. Methods In a multicentre prospective cohort study of infants with severe bronchiolitis ( i.e. bronchiolitis requiring hospitalisation), we profiled nasopharyngeal airway metagenome and virus at hospitalisation, and calculated the polygenic risk score of asthma. Using similarity network fusion clustering approach, we identified integrated metagenome–asthma genetic risk endotypes. In addition, we examined their longitudinal association with the risk of developing asthma by the age of 6 years. Results Out of 450 infants with bronchiolitis (median age 3 months), we identified five distinct endotypes, characterised by their nasopharyngeal metagenome, virus and asthma genetic risk profiles. Compared with endotype A infants (who clinically resembled “classic” bronchiolitis), endotype E infants (characterised by a high abundance of Haemophilus influenzae , high proportion of rhinovirus (RV)-A and RV-C infections and high asthma genetic risk) had a significantly higher risk of developing asthma (16.7% versus 35.9%; adjusted OR 2.24, 95% CI 1.02–4.97; p=0.046). The pathway analysis showed that endotype E had enriched microbial pathways ( e.g. glycolysis, l -lysine, arginine metabolism) and host pathways ( e.g. interferons, interleukin-6/Janus kinase/signal transducers and activators of transcription-3, fatty acids, major histocompatibility complex and immunoglobin-related) (false discovery rate (FDR)<0.05). Additionally, endotype E had a significantly higher proportion of neutrophils (FDR<0.05). Conclusion In this multicentre prospective cohort study of infant bronchiolitis, the clustering analysis of integrated-omics data identified biologically distinct endotypes with differential risks of developing asthma.

Year:

2024

Collaborators (14)

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Emma Vincent

Academic , Professor of Molecular Metabolism

University of Bristol

UNITED KINGDOM
View details

Wei Zheng

-

UNITED STATES
View details

Elizabeth Platz

Professor

Johns Hopkins University

UNITED STATES
View details

Sun-Seog Kweon

Chonnam National University

SOUTH KOREA
View details

Robert C. Grant

University Health Network

CANADA
View details

Bethany Van Guelpen

Umea University

SWEDEN
View details

Li Li

University of Virginia

UNITED STATES
View details

Philip Haycock

Senior Lecturer in Cancer Epidemiology

University of Bristol

UNITED KINGDOM
View details

Xia Jiang

Karolinska Institutet

SWEDEN
View details

Gianluca Severi

University of Firenze

ITALY
View details

Daniel D. Buchanan

Senior Research Fellow

University of Melbourne

AUSTRALIA
View details

Christopher Li

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Stephen Gruber

Professor

City Of Hope National Medical Center

UNITED STATES
View details